Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Companies are punished with monetary damages, but who’s out the dollars?

In November 2018, an Oklahoma jury returned a $25.5 million verdict against Aetna for improperly denying coverage for proton beam therapy, a treatment the company considered experimental. Evidence adduced at trial showed that no one in the oncology community considered that treatment experimental for the treatment of cancer and that the treatment, in fact, would have been covered by Medicare, had the plaintiff been aged 65 or over. It might even have been covered by Aetna if the plaintiff had been younger than 21, but she was not in this case.

Want to continue reading?
Become a Free ALM Digital Reader.

Benefits of a Digital Membership:

  • Free access to 3 articles* every 30 days
  • Access to the entire ALM network of websites
  • Unlimited access to the ALM suite of newsletters
  • Build custom alerts on any search topic of your choosing
  • Search by a wide range of topics

*May exclude premium content
Already have an account?


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.